Erdosteine

Records for this ingredient, by country (identity only).

ATC R05CB15 · 5 markets · 23 records

Erdosteine 5 markets · 23 records Forms
Filters
MarketCN 17SG 2TW 2GB 1

CN 17 records · 3 shown of 3 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 300 mgcapsule和坦厄多司坦坦通、阿多停、Manufacturer: FAMAR ITALIAS.p.A.、Manufacturer: 扬子江药业集团有限公司 also in SG·TW·GB
  • 150 mgtablet露畅厄多司坦Manufacturer: 山东罗欣药业集团股份有限公司、Manufacturer: 海南康瑞和生物医药科技有限公司
  • 150 mgcapsule坦通厄多司坦

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 300 mgcapsuleERDOMED HARD CAPSULES 300MG also in CN·TW·GB
  • 300 mgtabletERDOMED DISPERSIBLE TABLETS 300MG

TW 2 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 300 mgcapsuleErdotin 300mg capsules also in CN·SG·TW
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.